Nanovalent Pharmaceuticals, Inc.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 25, 2017 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 447 Total Citation Count
- Aug 05, 1994 Earliest Filing
- 11 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0199,233 Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface ReceptorAbandonedMay 11, 12Jul 17, 14[A61K]
2013/0129,635 POLYMERIZED SHELL LIPID MICROBUBBLES AND USES THEREOFAbandonedMay 24, 11May 23, 13[A61K]
2004/0253,184 Targeted polymerized liposome diagnostic and treatment agentsAbandonedMay 27, 03Dec 16, 04[A61K]
6569451 Targeted polymerized liposome diagnostic and treatment agentsExpiredFeb 26, 02May 27, 03[A61K, C07F]
2003/0082,103 Targeted therapeutic lipid constructs having cell surface targetsAbandonedOct 01, 02May 01, 03[A61K, C07F]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.